Wageningen, Netherlands

Gerrit Cornelis Angenent

This inventor holds 3 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 3 EPO patents. Top assignees: Stichting Wageningen Research, Kws Saat Se * Co. Kgaa. Active years: 2021-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gerrit Cornelis Angenent. Retrieved from https://idiyas.com/inventor/gerrit-cornelis-angenent

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 66.7

 

 

Average Co-Inventor Count = 4.3

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Gerrit Cornelis Angenent: Innovator in Plant Biotechnology

Introduction

Gerrit Cornelis Angenent is a prominent inventor based in Wageningen, Netherlands. He has made significant contributions to the field of plant biotechnology, particularly in the areas of haploid embryogenesis and the inhibition of bolting and flowering in plants. With a total of 3 patents, his work has the potential to revolutionize plant breeding programs.

Latest Patents

One of Angenent's latest patents focuses on haploid embryogenesis. This invention describes how a switch to haploid embryogenesis is controlled by the activity of histone deacetylases (HDACs). By blocking HDAC activity with inhibitors, such as trichostatin A (TSA), in male gametophytes, there is a significant increase in the proportion of cells that undergo embryogenic growth. Additionally, treatment with a specific HDAC inhibitor (SAHA) enhances the conversion of these embryos into seedlings. This method improves existing techniques for culturing microspores of angiosperm plants, making it possible to produce haploid embryos, haploid plants, and double haploid plants more effectively. The use of HDAC inhibitors can render species previously resistant to haploid embryogenesis useful in plant breeding programs.

Another notable patent addresses the inhibition of bolting and flowering in beta vulgaris plants. This invention provides means for inhibiting these processes through an isolated nucleic acid, which can be utilized to create transgenic plants that do not bolt or flower after vernalization. The patent also discloses vectors, transgenic and non-transgenic plants, and methods for producing such plants.

Career Highlights

Gerrit Cornelis Angenent has worked with several notable organizations, including Stichting Wageningen Research and KWS Saat SE & Co. KGaA. His expertise in plant biotechnology has positioned him as a key figure in advancing agricultural practices.

Collaborations

Angenent has collaborated with various professionals in his field, including Kimberly Boutilier and Mercedes Soriano Castan. These collaborations have further enriched his research and innovations.

Conclusion

Gerrit Cornelis Angenent is a distinguished inventor whose work in plant biotechnology has led to significant advancements in haploid embryogenesis and the control of flowering in plants. His contributions are poised to have a lasting impact on

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…